This article appears in the following Human Molecular Genetics issue: Stem Cells and Regeneration [View the issue table of contents]
Molecular basis of pluripotency
1 Division of Pediatric Hematology/Oncology, Children's Hospital Boston and Dana Farber Cancer Institute, Boston, MA 02115, USA 2 Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA 3 Division of Hematology, Brigham and Women's Hospital, Boston, MA 02115, USA, 4 Harvard Stem Cell Institute, Boston, MA 02115, USA 5 Howard Hughes Medical Institute, MD, USA
* To whom correspondence should be addressed. Email: george.daley{at}childrens.harvard.edu
Received December 31, 2007; Accepted February 13, 2008
Embryonic stem (ES) cells are pluripotent and capable of self-renewal, thus holding promise for regenerative medicine. Recent studies have begun to provide insights into the molecular mechanisms underlying pluripotency and self-renewal. In this article, we discuss the roles of transcriptional regulation, epigenetic regulation and miRNAs in the maintenance of pluripotency and the differentiation of ES cells.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
J. Butcher, H. Abdou, K. Morin, and Y. Liu Micromanaging Oligodendrocyte Differentiation by Noncoding RNA: Toward a Better Understanding of the Lineage Commitment Process J. Neurosci., April 29, 2009; 29(17): 5365 - 5366. [Full Text] [PDF] |
||||
![]() |
P. Rangan, M. DeGennaro, and R. Lehmann Regulating Gene Expression in the Drosophila Germ Line Cold Spring Harb Symp Quant Biol, March 6, 2009; (2009) sqb.2008.73.057v1. [Abstract] [PDF] |
||||

